Hansa Investment Company Limited Stock

Equities

HAN

BMG428941162

Investment Management & Fund Operators

Delayed London S.E. 11:35:24 2024-05-16 am EDT 5-day change 1st Jan Change
219 GBX 0.00% Intraday chart for Hansa Investment Company Limited -1.79% +9.50%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * - Sales 2025 * - Capitalization 260M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * -
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
1.46%
Yield 2025 *
1.46%
Free-Float 76.07%
More Fundamentals * Assessed data
Dynamic Chart
Hansa Investment Company Limited Expects to Pay Four Interim Dividends for Its Financial Year Ending 31 March 2025 CI
Hansa Investment Company Limited Announces Fourth Interim Dividend for the Financial Year Ended 31 March 2024, Payable on 31 May 2024 CI
Hansa Investment Company Limited Declares Third Interim Dividend for the Financial Year Ending 31 March 2024, Payable on 23 February 2024 CI
Hansa Investment Company Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Hansa Investment Company Limited Declares Second Interim Dividend for the Financial Year Ending 31 March 2024, Payable on November 24, 2023 CI
Hansa Biopharma Announces Encouraging High-Level Results for First-In-Human Trial of HNSA-5487 CI
Hansa Investment Company Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Hansa Investment Company Limited Appoints Dr. Hitto Kaufmann as Chief Scientific Officer CI
Hansa Investment Company Limited Announces First Patient Treated with Imlifidase in an Investigator-Initiated Phase 2 Study in Anca-Associated Vasculitis CI
Hansa Investment Company Limited Announces First Interim Dividend for the Year Ended 31 March 2024, Payable on August 25, 2023 CI
Hansa Biopharma Announces Positive Reimbursement Decision for Idefirix in Belgium as Desensitization Treatment for Highly Sensitized Patients in Kidney Transplantation CI
Hansa Investment Company Limited Expects to Pay Four Interim Dividends for its Financial Year Ending 31 March 2024, Payable on August 2023, November 2023, February 2024 and May 2024 Respectively CI
Hansa Investment Company Limited Announces Its Fourth Interim Distribution for the Company's Financial Year Ended March 31, 2023, Payable on 26 May 2023 CI
Hansa Investment Company Limited Announces Executive Changes CI
Hansa Investment Company Limited Announces Third Interim Distribution for the Financial Year Ended March 31, 2023, Payable on February 24, 2023 CI
More news
1 week-1.79%
Current month+4.29%
1 month+4.53%
3 months+2.82%
6 months+10.05%
Current year+9.50%
More quotes
1 week
214.00
Extreme 214
220.40
1 month
198.80
Extreme 198.8
230.80
Current year
192.00
Extreme 192
230.80
1 year
161.00
Extreme 161
230.80
3 years
161.00
Extreme 161
248.00
5 years
123.77
Extreme 123.77
248.00
10 years
123.77
Extreme 123.77
248.00
More quotes
Members of the board TitleAgeSince
Director/Board Member 66 -
Chairman 76 19-07-31
Director/Board Member 56 19-07-31
More insiders
Date Price Change Volume
24-05-16 219 0.00% 4,800
24-05-15 219 0.00% 3,698
24-05-14 219 -0.45% 7,312
24-05-13 220 -0.45% 9,000
24-05-10 221 -0.90% 10,701

Delayed Quote London S.E., May 16, 2024 at 11:35 am EDT

More quotes
Hansa Investment Company Limited is an externally managed closed-ended investment company. The Company’s investment objective is to grow the net assets of the Company over the medium to long-term by investing in a diversified and multi-strategy portfolio. The Company seeks to achieve its investment objective by investing in third-party funds, global equities and other international financial securities. The Company also invests in quoted and unquoted securities. It invests in various sectors, including industrials, financials, information technology, health care, consumer discretionary, materials, communications services, energy and others. Hansa Capital Partners LLP is the investment manager of the Company.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.19 GBP
Average target price
2.1 GBP
Spread / Average Target
-4.11%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW